PASITHEA THERAPEUTICS CORP. (KTTA) Operating income 2021–2025
PASITHEA THERAPEUTICS CORP. (KTTA) annual operating income history from SEC filings — each fiscal year as reported.
-$20.9MFY2025 · since FY2021: -$4.5M → -$20.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.9M | -46.4% |
| FY2024 | -$14.2M | +10.8% |
| FY2023 | -$16.0M | -26.9% |
| FY2022 | -$12.6M | -179.3% |
| FY2021 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KTTA financial trends
KTTA RevenueKTTA Net incomeKTTA Net marginKTTA Gross profitKTTA Gross marginKTTA Operating marginKTTA Operating cash flowKTTA Free cash flowKTTA Capital expendituresKTTA Return on equityKTTA Stock buybacksKTTA Dividends paidKTTA Total assetsKTTA Total liabilitiesKTTA Shareholders’ equityKTTA overview →